Showing 991-1000 of 20877 results for "".
- SLNB vs ALND in TNBC After Neoadjuvant Chemo-Immunotherapyhttps://reachmd.com/news/slnb-vs-alnd-in-tnbc-after-neoadjuvant-chemo-immunotherapy/2487996/Key Takeaways Among selected women with cN1-3, cM0 TNBC who achieved ypN0 after NAC with or without ICIs and had at least 3 examined lymph nodes, SLNB accounted for 82.5% of axillary operations. After NAC alone, propensity-matched 5-year overall survival was signific
- Esketamine Improved Induction Hemodynamics in Elderly Surgeryhttps://reachmd.com/news/esketamine-improved-induction-hemodynamics-in-elderly-surgery/2488003/Key Takeaways Among elderly patients undergoing elective surgery with tracheal intubation general anesthesia, esketamine during induction was associated with higher mean arterial pressure across post-induction and post-intubation measurements than saline. Early snuff
- Imsidolimab in Generalized Pustular Psoriasis: Efficacy and Safetyhttps://reachmd.com/news/imsidolimab-generalized-pustular-psoriasis-efficacy-safety/2487984/Key Takeaways Week 4 clear or almost clear status was reported more often with imsidolimab than with placebo. The phase 3 program included an initial efficacy trial followed by a relapse-prevention study. Across 104 weeks of follow-up, no serious ad
- Spinal Cord Injury Axon Regrowth Barriers and Therapieshttps://reachmd.com/news/spinal-cord-injury-axon-regrowth-barriers-and-therapies/2487965/Key Takeaways In spinal cord injury, failed axonal regeneration reflects both the inhibitory lesion microenvironment and the reduced intrinsic growth capacity of mature neurons. Glial scarring is biphasic, with a protective role during the first 0–2 weeks after injur
- Phase III Infant Trial Supports DTcP Immunogenicityhttps://reachmd.com/news/phase-iii-infant-trial-supports-dtcp-immunogenicity/2487947/Key Takeaways In a 3-arm, Phase III comparison, 1,140 healthy infants aged 90 to 119 days were enrolled; DTcP and co-purified DTaP were randomized 1:1, the DTaP-IPV-Hib comparator arm was open-label and nonrandomized, and all vaccines were given at 3, 4, and 5 months.
- Financial Toxicity Common in Insured Brazilian Cancer Patientshttps://reachmd.com/news/financial-toxicity-insured-brazilian-cancer-patients/2487932/Key Takeaways Among 1,343 privately insured patients with breast, prostate, colorectal, or lung cancer treated in a private oncology network in Rio de Janeiro and São Paulo, 23% reported baseline financial burden, 25% reported financial burden at 6 months, and 16% developed Q
- Resolve Trial Tests Guideline-Informed Physical Therapy for Low Back Painhttps://reachmd.com/news/resolve-trial-tests-guideline-informed-physical-therapy-for-low-back-pain/2487903/Key Takeaways The post-training CPG+PIPT period was associated with fewer opioid prescriptions over 12 months. ODI and DVPRS scores improved slightly more over time during the CPG+PIPT period, but differences were not clinically meaningful at 6 and 12
- Study: Intentional Outdoor Tanning Common Among US Adults, Especially Young Womenhttps://reachmd.com/news/intentional-outdoor-tanning-remains-common-among-us-adults-especially-young-women/2487924/Intentional outdoor tanning remains a common behavior among US adults, particularly younger women, according to a large cross-sectional analysis of nationally representative survey data published online in JAMA Dermatology.<
- TIVA Versus Inhalational Anesthesia in Sleeve Gastrectomy Trialhttps://reachmd.com/news/tiva-versus-inhalational-anesthesia-in-sleeve-gastrectomy-trial/2487902/Key Takeaways Total intravenous anesthesia was associated with shorter recovery time and lower postoperative nausea and vomiting than inhalational anesthesia. Visual analog scale pain scores were lower at 15 and 30 minutes, with no significant differen
- Commercial Cardiology Prices Varied Widely Across US Insurershttps://reachmd.com/news/commercial-cardiology-prices-varied-widely-across-us-insurers/2487914/Key Takeaways Using April 2025 Transparency in Coverage data reflecting 2023 contract-year claims, investigators analyzed negotiated prices for 32 common cardiology services across Blue Cross Blue Shield, UnitedHealthcare, Aetna, and Cigna Healthcare, insurers representing 78